Drugs · Brain health technique
Nicotinamide Riboside / NMN
Evidence grade: Experimental

NAD⁺ precursors that aim to restore cellular energy metabolism and mitochondrial function, including nicotinamide riboside (NR; Niagen®) and nicotinamide mononucleotide (NMN), both used in ongoing human longevity and neuroprotection trials.
- Practice
- Drugs
- Principle
- Treatment
- Tactic
- Emerging Longevity / Neuroregenerative Agents
- Evidence grade
- Experimental
- Strength of evidence
- Low
How to practice Nicotinamide Riboside / NMN
Only use clinical-grade formulations from verified manufacturers or within research trials. Typical studied doses: 250–1000 mg/day orally. Over-the-counter products vary in purity and stability. Safe short-term, but long-term outcomes unknown. Avoid exaggerated claims; cognitive benefits remain unproven pending phase 3 results.
The evidence behind Nicotinamide Riboside / NMN
NMN is a molecule that your body converts to NAD⁺. Your natural NAD⁺ declines with age, which weakens DNA repair and your mitochondria. NR and NMN supplements raise NAD⁺ levels in people, and small studies show improvements in some lab measures of metabolic and blood vessel health. Higher NAD⁺ also supports sirtuins. Large human trials have yet to show that these supplements extend lifespan.
Impact on brain health
In animal studies of Alzheimer's and of reduced blood supply to the brain (ischemia), NR and NMN protect nerve cells. Higher NAD⁺ supports nerve cells' resilience. Large human trials have yet to show a benefit for memory or thinking.
Reviewed by BetterBrain's clinical advisors · Updated November 2026 · Our science
More Drugs techniques
Pair this with other habits from the same practice.

Evidence grade: Context Dependent
Anti-Amyloid Monoclonal Antibodies
FDA-approved biologic drugs that target beta-amyloid plaques to slow Alzheimer’s progression, including lecanemab (Leqembi®), donanemab (Kisunla™).

Evidence grade: Context Dependent
Antihypertensives
Medications that lower blood pressure to protect vascular and brain health, including ACE inhibitors (lisinopril, enalapril), ARBs (losartan, valsartan), calcium channel blockers…

Evidence grade: Context Dependent
GLP-1 Receptor Agonists
A class of injectable or oral medications that mimic the hormone glucagon-like peptide-1 (GLP-1) to improve insulin sensitivity, suppress appetite, and reduce inflammation.
Take control of your brain health
BetterBrain gives you a personalized protocol of techniques like these, backed by science and tailored to you.